From the Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Mass (O.R.B., P.B., J.P., C.C., I.B., P.P., A.B.); and Department of Radiology, University of Texas Southwestern Medical Center, 2201 Inwood Rd, 2nd Floor, Suite 202, Dallas, TX 75390-9085 (I.P.).
Radiology. 2016 Mar;278(3):752-61. doi: 10.1148/radiol.2015140972. Epub 2015 Sep 4.
To evaluate growth kinetics of asymptomatic small (<2 cm) incidental pancreatic cysts and to assess potential implications of these in the context of current American College of Radiology recommendations.
This institutional review board-approved HIPAA-compliant retrospective study with waiver of informed consent included patients with asymptomatic small incidental pancreatic cysts (diameter, 5-20 mm) with two or more magnetic resonance (MR) examinations performed at least 6 months apart at a tertiary institution. The largest cyst dimension was measured on T2-weighted single-shot fast spin-echo images by one of six radiologists (1-3 years of experience) who were trained to measure pancreatic cysts in a similar manner. All analysis was conducted at the patient level by choosing the cyst that exhibited the greatest growth over the follow-up period in each patient. Fisher exact, χ(2), and Kruskal-Wallis tests and analysis of variance were used to test correlation between cyst characteristics and growth.
A total of 259 patients (mean age, 65 years ± 11 [standard deviation], male-to-female ratio, 42:58) with 370 asymptomatic small incidental pancreatic cysts were included. At presentation, median cyst size was 9.4 mm (interquartile range [IQR], 7.0-12.2 mm), and 64 patients (25%; 95% confidence interval [CI]: 20, 30) had septations. The median imaging follow-up period was 2.2 years (IQR, 1.2-3.9 years; range, 0.5-11.0 years), with a median of three MR examinations (IQR, two to four examinations) per patient. In 171 (66%; 95% CI: 60, 72) of the 259 patients, cysts remained stable; in 18 (7%; 95% CI: 4, 11), cysts shrank; and in 70 (27%; 95% CI: 22, 33), cysts grew (median total growth and median annual growth of 4.8 mm and 2.3 mm/y, respectively). Age, cyst size, and cyst septation at presentation were not predictive of growth. Overall, 29 (11%), 16 (6%), and four (1.5%) of the cysts increased in size after 1, 2, and 3 years of initial stability, respectively. Of the 18 patients who underwent pancreatic surgery, only one patient with an intraductal papillary mucinous neoplasm had high-grade dysplasia. One patient developed pancreatic adenocarcinoma remotely at the location of the pancreatic cyst diagnosed 11 months prior.
In the majority of patients, asymptomatic small incidental pancreatic cysts remained stable during a median follow-up period of 2.2 years; however, in 27% of patients, cysts increased in size over time, with 11% growing after an initial 1-year period of stability. Current American College of Radiology recommendations to discontinue imaging follow-up after 1 year of stability may need to be reevaluated.
评估无症状小(<2cm)偶然胰腺囊肿的生长动力学,并评估当前美国放射学院建议背景下这些囊肿的潜在影响。
本研究经机构审查委员会批准,符合 HIPAA 规定,对至少在一家三级医疗机构进行了两次以上至少间隔 6 个月的磁共振(MR)检查的无症状小(直径 5-20mm)偶然胰腺囊肿患者进行了回顾性研究,且患者均签署了放弃知情同意书。在 T2 加权单次快速自旋回波图像上,由 6 位放射科医生(1-3 年经验)中的一位测量最大囊肿尺寸,这 6 位医生均经过类似的胰腺囊肿测量培训。所有分析均在患者水平上进行,方法是选择每位患者在随访期间生长最大的囊肿。采用 Fisher 确切检验、χ(2)检验、Kruskal-Wallis 检验和方差分析来检验囊肿特征与生长之间的相关性。
共纳入 259 例(平均年龄 65 岁±11[标准差],男女比例 42:58)无症状小偶然胰腺囊肿 370 例。在初次就诊时,囊肿中位大小为 9.4mm(四分位距[IQR]:7.0-12.2mm),64 例(25%;95%置信区间[CI]:20,30)有分隔。中位影像学随访时间为 2.2 年(IQR:1.2-3.9 年;范围:0.5-11.0 年),中位每位患者进行了 3 次 MR 检查(IQR:2 至 4 次)。在 259 例患者中,171 例(66%;95%CI:60,72)的囊肿保持稳定;18 例(7%;95%CI:4,11)的囊肿缩小;70 例(27%;95%CI:22,33)的囊肿生长(中位总生长和中位年生长分别为 4.8mm 和 2.3mm/y)。在初次就诊时,年龄、囊肿大小和囊肿分隔与生长均无相关性。总体而言,分别有 29 例(11%)、16 例(6%)和 4 例(1.5%)的囊肿在初次稳定后 1、2 和 3 年时体积增大。在接受胰腺手术的 18 例患者中,只有 1 例胰腺导管内乳头状黏液性肿瘤患者有高级别异型增生。1 例患者在诊断为胰腺囊肿 11 个月后,在胰腺囊肿所在部位发生了远处胰腺腺癌。
在大多数患者中,无症状小偶然胰腺囊肿在中位 2.2 年的随访期间保持稳定;然而,在 27%的患者中,囊肿随时间增大,其中 11%在最初 1 年稳定期后增大。当前美国放射学院建议在稳定后 1 年停止影像学随访,可能需要重新评估。